286 related articles for article (PubMed ID: 20038828)
21. Technology assessment of medical devices at the Center for Devices and Radiological Health.
Kessler L; Richter K
Am J Manag Care; 1998 Sep; 4 Spec No():SP129-35. PubMed ID: 10185989
[TBL] [Abstract][Full Text] [Related]
22. Selective reporting in trials of high risk cardiovascular devices: cross sectional comparison between premarket approval summaries and published reports.
Chang L; Dhruva SS; Chu J; Bero LA; Redberg RF
BMJ; 2015 Jun; 350():h2613. PubMed ID: 26063311
[TBL] [Abstract][Full Text] [Related]
23. Health device legislation: an overview of the law and its impact on respiratory care.
Bancroft ML; Steen JA
Respir Care; 1978 Dec; 23(12):1179-84. PubMed ID: 10315033
[TBL] [Abstract][Full Text] [Related]
24. Medical devices; gastroenterology-urology devices; nonimplanted, peripheral electrical continence device. Food and Drug Administration, HHS. Final rule.
Fed Regist; 2000 Apr; 65(68):18236-7. PubMed ID: 11010624
[TBL] [Abstract][Full Text] [Related]
25. Mutual Recognition of the Food and Drug Administration and European Community Member State Conformity Assessment Procedures; pharmaceutical GMP inspection reports, medical device quality system evaluation reports, and certain medical device premarket evaluation reports--FDA. Proposed rule.
Fed Regist; 1998 Apr; 63(69):17744-71. PubMed ID: 10177764
[TBL] [Abstract][Full Text] [Related]
26. Pediatric cardiovascular safety: challenges in drug and device development and clinical application.
Bates KE; Vetter VL; Li JS; Cummins S; Aguel F; Almond C; Dubin AM; Elia J; Finkle J; Hausner EA; Joseph F; Karkowsky AM; Killeen M; Lemacks J; Mathis L; McMahon AW; Pinnow E; Rodriguez I; Stockbridge NL; Stockwell M; Tassinari M; Krucoff MW
Am Heart J; 2012 Oct; 164(4):481-92. PubMed ID: 23067905
[TBL] [Abstract][Full Text] [Related]
27. Food and Drug Administration's perspectives on pediatric cardiac assist devices.
Chen EA; Patel-Raman SM; Berman MR; Zuckerman BD
ASAIO J; 2008; 54(2):147-9. PubMed ID: 18356646
[TBL] [Abstract][Full Text] [Related]
28. Medical devices; procedures for premarket notification, premarket approval, classification, performance standards establishment, banning devices, and availability of regulatory hearings--FDA. Final rule.
Fed Regist; 1992 Dec; 57(238):58400-6. PubMed ID: 10123143
[TBL] [Abstract][Full Text] [Related]
29. Lessons learned from independent central review.
Ford R; Schwartz L; Dancey J; Dodd LE; Eisenhauer EA; Gwyther S; Rubinstein L; Sargent D; Shankar L; Therasse P; Verweij J
Eur J Cancer; 2009 Jan; 45(2):268-74. PubMed ID: 19101138
[TBL] [Abstract][Full Text] [Related]
30. Pharmaceuticals and medical devices: medical devices. End-of-year issue brief.
Chaps NA
Issue Brief Health Policy Track Serv; 2010 Jan; ():1-25. PubMed ID: 20217916
[No Abstract] [Full Text] [Related]
31. Marketing approval for the lithotripter.
Nightingale SL; Young FE
Isr J Med Sci; 1986; 22(7-8):519-23. PubMed ID: 3781809
[TBL] [Abstract][Full Text] [Related]
32. Obstetric and gynecology devices; effective date of requirement for premarket approval for glans sheath devices. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2002 Jun; 67(115):40848-9. PubMed ID: 12068899
[TBL] [Abstract][Full Text] [Related]
33. Medical devices; 30-day notices and 135-day PMA supplement review--FDA. Direct final rule; withdrawal.
Fed Regist; 1998 Aug; 63(154):42699. PubMed ID: 10182563
[TBL] [Abstract][Full Text] [Related]
34. The Lumbar I/F Cage for posterior lumbar interbody fusion with the variable screw placement system: 10-year results of a Food and Drug Administration clinical trial.
Brantigan JW; Neidre A; Toohey JS
Spine J; 2004; 4(6):681-8. PubMed ID: 15541703
[TBL] [Abstract][Full Text] [Related]
35. Clinical end points in coronary stent trials: a case for standardized definitions.
Cutlip DE; Windecker S; Mehran R; Boam A; Cohen DJ; van Es GA; Steg PG; Morel MA; Mauri L; Vranckx P; McFadden E; Lansky A; Hamon M; Krucoff MW; Serruys PW;
Circulation; 2007 May; 115(17):2344-51. PubMed ID: 17470709
[TBL] [Abstract][Full Text] [Related]
36. Medical devices; effective date of requirement for premarket approval for three preamendment class III devices. Food and Drug Administration, HHS. Final rule.
Fed Regist; 2000 Apr; 65(72):19833-4. PubMed ID: 11010634
[TBL] [Abstract][Full Text] [Related]
37. Medical devices; reclassification of three anesthesiology preamendments class III devices into class II. Final rule.
Food and Drug Administration, HHS
Fed Regist; 2001 Nov; 66(221):57366-8. PubMed ID: 11776278
[TBL] [Abstract][Full Text] [Related]
38. Medical devices; exemption from premarket notification requirements; class I devices; technical amendment. Final rule; technical amendment.
Food and Drug Administration. HHS
Fed Regist; 2001 Jul; 66(143):38786-819. PubMed ID: 11725800
[TBL] [Abstract][Full Text] [Related]
39. Clinical chemistry and clinical toxicology devices; classification of B-type natriuretic peptide test system. Food and Drug Administration, HHS. Final rule.
Fed Regist; 2001 Feb; 66(40):12733-4. PubMed ID: 11503864
[TBL] [Abstract][Full Text] [Related]
40. Safety and effectiveness considerations for clinical studies of visual prosthetic devices.
Cohen ED
J Neural Eng; 2007 Mar; 4(1):S124-9. PubMed ID: 17325410
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
